ACE2 and pneumonia: SARS-CoV-2's entry into the lung tissue, facilitated by the angiotensin converting enzyme-2 (ACE-2), creates exaggerated inflammatory response and widespread dissemination of the virus throughout the lung parenchyma, producing pneumonia [5].